These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 12001649)
61. [Treatment of neurodegenerative diseases: new perspectives]. Członkowska A; Kurkowska-Jastrzebska I Neurol Neurochir Pol; 2001; 35(4 Suppl):147-56. PubMed ID: 11873614 [TBL] [Abstract][Full Text] [Related]
62. Chronic expression of low levels of tumor necrosis factor-alpha in the substantia nigra elicits progressive neurodegeneration, delayed motor symptoms and microglia/macrophage activation. De Lella Ezcurra AL; Chertoff M; Ferrari C; Graciarena M; Pitossi F Neurobiol Dis; 2010 Mar; 37(3):630-40. PubMed ID: 19969084 [TBL] [Abstract][Full Text] [Related]
63. Role of inflammatory factors in neurodegeneration. Członkowska A; Kurkowska-Jastrzebska I; Członkowski A Neurol Neurochir Pol; 2001; 35 Suppl 3():13-22. PubMed ID: 12001649 [No Abstract] [Full Text] [Related]
65. Idiopathic Parkinson's disease: a review of clinical types and pathology. Olasode BJ Niger J Med; 2001; 10(3):116-20. PubMed ID: 11806009 [TBL] [Abstract][Full Text] [Related]
66. The role of iron in Parkinson disease and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity. Yantiri F; Andersen JK IUBMB Life; 1999 Aug; 48(2):139-41. PubMed ID: 10794588 [TBL] [Abstract][Full Text] [Related]
67. Central role of alpha-synuclein oligomers in neurodegeneration in Parkinson disease. Kazantsev AG; Kolchinsky AM Arch Neurol; 2008 Dec; 65(12):1577-81. PubMed ID: 19064744 [TBL] [Abstract][Full Text] [Related]
68. Neural degeneration in Parkinson's disease. Riederer P; Reichmann H; Janetzky B; Sian J; Lesch KP; Lange KW; Double KL; Nagatsu T; Gerlach M Adv Neurol; 2001; 86():125-36. PubMed ID: 11553969 [No Abstract] [Full Text] [Related]
69. The structure and mechanism of neurotransmitter receptors. Implications for the structure and function of the central nervous system. Strange PG Biochem J; 1988 Jan; 249(2):309-18. PubMed ID: 2893605 [No Abstract] [Full Text] [Related]
70. Neuroinflammation and oxidative stress: co-conspirators in the pathology of Parkinson's disease. Taylor JM; Main BS; Crack PJ Neurochem Int; 2013 Apr; 62(5):803-19. PubMed ID: 23291248 [TBL] [Abstract][Full Text] [Related]
72. The role of Ser129 phosphorylation of α-synuclein in neurodegeneration of Parkinson's disease: a review of in vivo models. Sato H; Kato T; Arawaka S Rev Neurosci; 2013; 24(2):115-23. PubMed ID: 23314528 [TBL] [Abstract][Full Text] [Related]
73. Neural degeneration and the transport of neurotransmitters. Edwards RH Ann Neurol; 1993 Nov; 34(5):638-45. PubMed ID: 7902065 [TBL] [Abstract][Full Text] [Related]
74. The MPTP tale: pathway to prevention of Parkinson's disease? Williams A; Waring R Br J Hosp Med; 1993 May 19-Jun 1; 49(10):716-9. PubMed ID: 8324592 [TBL] [Abstract][Full Text] [Related]